PATRIA INVESTMENTS LTD-A (PAX)

KYG694511059 - Common Stock

13.4  -0.2 (-1.47%)

After market: 13.3313 -0.07 (-0.51%)

Fundamental Rating

6

Taking everything into account, PAX scores 6 out of 10 in our fundamental rating. PAX was compared to 210 industry peers in the Capital Markets industry. While PAX has a great health rating, its profitability is only average at the moment. PAX is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, PAX could be worth investigating further for growth investing!.



6

1. Profitability

1.1 Basic Checks

In the past year PAX was profitable.
PAX had positive earnings in each of the past 5 years.
PAX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of PAX (12.83%) is better than 93.75% of its industry peers.
PAX has a Return On Equity of 23.37%. This is amongst the best in the industry. PAX outperforms 90.38% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.70%, PAX belongs to the top of the industry, outperforming 89.42% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PAX is above the industry average of 10.67%.
Industry RankSector Rank
ROA 12.83%
ROE 23.37%
ROIC 14.7%
ROA(3y)12.39%
ROA(5y)29.22%
ROE(3y)20.12%
ROE(5y)48.19%
ROIC(3y)15.18%
ROIC(5y)36.6%

1.3 Margins

The Profit Margin of PAX (39.13%) is better than 75.00% of its industry peers.
In the last couple of years the Profit Margin of PAX has declined.
With a decent Operating Margin value of 37.17%, PAX is doing good in the industry, outperforming 61.54% of the companies in the same industry.
In the last couple of years the Operating Margin of PAX has declined.
Looking at the Gross Margin, with a value of 54.62%, PAX is in line with its industry, outperforming 56.25% of the companies in the same industry.
In the last couple of years the Gross Margin of PAX has declined.
Industry RankSector Rank
OM 37.17%
PM (TTM) 39.13%
GM 54.62%
OM growth 3Y-14.45%
OM growth 5Y-3.61%
PM growth 3Y-12.57%
PM growth 5Y-2.65%
GM growth 3Y-8.57%
GM growth 5Y-2.25%

7

2. Health

2.1 Basic Checks

The number of shares outstanding for PAX has been increased compared to 1 year ago.
Compared to 5 years ago, PAX has more shares outstanding
PAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 3.75 indicates that PAX is not in any danger for bankruptcy at the moment.
PAX has a Altman-Z score of 3.75. This is amongst the best in the industry. PAX outperforms 81.25% of its industry peers.
PAX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.75
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.17 indicates that PAX should not have too much problems paying its short term obligations.
PAX has a Current ratio (1.17) which is in line with its industry peers.
PAX has a Quick Ratio of 1.17. This is a normal value and indicates that PAX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.17, PAX is in line with its industry, outperforming 52.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17

7

3. Growth

3.1 Past

PAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.10%, which is quite impressive.
PAX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 19.33% yearly.
Looking at the last year, PAX shows a very strong growth in Revenue. The Revenue has grown by 43.69%.
PAX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 25.39% yearly.
EPS 1Y (TTM)40.1%
EPS 3Y20.19%
EPS 5Y19.33%
EPS growth Q2Q15%
Revenue 1Y (TTM)43.69%
Revenue growth 3Y41.76%
Revenue growth 5Y25.39%
Revenue growth Q2Q11.4%

3.2 Future

The Earnings Per Share is expected to grow by 21.22% on average over the next years. This is a very strong growth
Based on estimates for the next years, PAX will show a small growth in Revenue. The Revenue will grow by 7.86% on average per year.
EPS Next Y29.37%
EPS Next 2Y22.06%
EPS Next 3Y21.22%
EPS Next 5YN/A
Revenue Next Year18.76%
Revenue Next 2Y19.6%
Revenue Next 3Y7.86%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.55, the valuation of PAX can be described as very reasonable.
63.46% of the companies in the same industry are more expensive than PAX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of PAX to the average of the S&P500 Index (24.67), we can say PAX is valued rather cheaply.
The Price/Forward Earnings ratio is 8.16, which indicates a very decent valuation of PAX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PAX indicates a somewhat cheap valuation: PAX is cheaper than 78.37% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.02, PAX is valued rather cheaply.
Industry RankSector Rank
PE 11.55
Fwd PE 8.16

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PAX may justify a higher PE ratio.
A more expensive valuation may be justified as PAX's earnings are expected to grow with 21.22% in the coming years.
PEG (NY)0.39
PEG (5Y)0.6
EPS Next 2Y22.06%
EPS Next 3Y21.22%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.89%, PAX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.23, PAX pays a bit more dividend than its industry peers.
PAX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 7.89%

5.2 History

PAX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

182.21% of the earnings are spent on dividend by PAX. This is not a sustainable payout ratio.
DP182.21%
EPS Next 2Y22.06%
EPS Next 3Y21.22%

PATRIA INVESTMENTS LTD-A

NASDAQ:PAX (4/30/2024, 4:22:16 PM)

After market: 13.3313 -0.07 (-0.51%)

13.4

-0.2 (-1.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.01B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 7.89%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 11.55
Fwd PE 8.16
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.39
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 12.83%
ROE 23.37%
ROCE
ROIC
ROICexc
ROICexgc
OM 37.17%
PM (TTM) 39.13%
GM 54.62%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)40.1%
EPS 3Y20.19%
EPS 5Y
EPS growth Q2Q
EPS Next Y29.37%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)43.69%
Revenue growth 3Y41.76%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y